Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationLiver TransplantationHematopoietic Stem Cell TransplantationTransplantation ConditioningAnemia, AplasticLeukemiaTransplantation ChimeraGraft SurvivalTissue DonorsKidney TransplantationBusulfanHistocompatibility TestingBone and BonesBone Marrow PurgingHematopoietic Stem CellsHistocompatibilityTransplantation, IsogeneicCyclophosphamideRecurrenceBone Marrow DiseasesHematopoiesisGraft RejectionImmunosuppressive AgentsCombined Modality TherapyHeart TransplantationTreatment OutcomeStem Cell TransplantationMice, Inbred C57BLTime FactorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRadiation ChimeraLeukemia, Myeloid, AcuteTransplantation ImmunologyHematologic NeoplasmsRemission InductionLung TransplantationT-LymphocytesBone Marrow ExaminationPrecursor Cell Lymphoblastic Leukemia-LymphomaImmunosuppressionHepatic Veno-Occlusive DiseaseGraft vs Host ReactionLeukemia, MyeloidAcute DiseaseLymphocyte DepletionLymphoma, Non-HodgkinLeukocyte TransfusionBone Marrow NeoplasmsOrgan TransplantationRetrospective StudiesHLA AntigensSurvival AnalysisColony-Forming Units AssayChimeraSevere Combined ImmunodeficiencyMyelodysplastic SyndromesCyclosporineLeukocyte CountFlow CytometryPeripheral Blood Stem Cell TransplantationActuarial AnalysisLymphocyte TransfusionHematologic DiseasesAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesCells, CulturedGranulocyte Colony-Stimulating FactorSurvival RateCell DifferentiationNuclear FamilyCarmustineCytomegalovirus InfectionsCell TransplantationGraft vs Tumor EffectSpleenPancytopeniaGraft vs Leukemia EffectCytarabinePancreas TransplantationBone RemodelingMelphalanAntigens, CD34Disease-Free SurvivalIslets of Langerhans TransplantationLeukocytes, MononuclearBlood CellsCord Blood Stem Cell TransplantationMice, Inbred BALB CMultiple MyelomaLymphocytesTransplantationLymphomaEtoposideImmunophenotyping